CERo Therapeutics Holdings Inc (NASDAQ:CERO) has a beta value of 0.74 and has seen 5.56 million shares traded in the recent trading session. The company, currently valued at $2.22M, closed the recent trade at $0.73 per share which meant it lost -$0.02 on the day or -2.80% during that session. The CERO stock price is -51406.85% off its 52-week high price of $376.00 and 9.59% above the 52-week low of $0.66. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.71 million shares traded. The 3-month trading volume is 765.05K shares.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Sporting -2.80% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CERO stock price touched $0.73 or saw a rise of 28.79%. Year-to-date, CERo Therapeutics Holdings Inc shares have moved -87.83%, while the 5-day performance has seen it change -23.16%. Over the past 30 days, the shares of CERo Therapeutics Holdings Inc (NASDAQ:CERO) have changed -56.29%. Short interest in the company has seen 0.84 million shares shorted with days to cover at 1.74.

CERo Therapeutics Holdings Inc (CERO) estimates and forecasts

The company’s shares have lost -92.26% over the past 6 months.

CERO Dividends

CERo Therapeutics Holdings Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s Major holders

Insiders own 18.77% of the company shares, while shares held by institutions stand at 4.47% with a share float percentage of 5.50%. Investors are also buoyed by the number of investors in a company, with CERo Therapeutics Holdings Inc having a total of 22.0 institutions that hold shares in the company.